Document Detail

Methylprednisolone treatment in aplastic anaemia.
MedLine Citation:
PMID:  3524596     Owner:  NLM     Status:  MEDLINE    
Twenty patients with aplastic anaemia were treated with a short term bolus of methylprednisolone. Seven patients were refractory to anabolic steroids and were observed in very long follow-up periods of 14-104 months. Thirteen patients had never been treated. The latter group also received anabolic steroids. Five out of 20 patients responded to the treatment while the remaining patients did not or died. Responders among patients refractory to anabolic steroids had shorter duration of disease compared to non-responders. No recurrence of aplasia was observed in all responders.
S Issaragrisil; A Piankijagum
Related Documents :
4037416 - Bone marrow status of anaemic pregnant women on supplemental iron and folic acid in a n...
20922526 - The role of zinc protoporphyrin measurement in the differentiation between primary myel...
19593686 - Contribution of histological, serological, and genetic factors to the clinical heteroge...
3071336 - The use of recombinant human erythropoietin (epo) to correct the anemia of end-stage re...
11711686 - Managing ambulatory anticoagulation.
21349256 - Granzymes a and b levels in serum of patients with amyotrophic lateral sclerosis.
Publication Detail:
Type:  Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Asian Pacific journal of allergy and immunology / launched by the Allergy and Immunology Society of Thailand     Volume:  4     ISSN:  0125-877X     ISO Abbreviation:  Asian Pac. J. Allergy Immunol.     Publication Date:  1986 Jun 
Date Detail:
Created Date:  1986-09-16     Completed Date:  1986-09-16     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  8402034     Medline TA:  Asian Pac J Allergy Immunol     Country:  THAILAND    
Other Details:
Languages:  eng     Pagination:  29-32     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Anabolic Agents / therapeutic use
Anemia, Aplastic / drug therapy*
Chronic Disease
Clinical Trials as Topic
Drug Resistance
Methylprednisolone / administration & dosage,  therapeutic use*
Middle Aged
Reg. No./Substance:
0/Anabolic Agents; 83-43-2/Methylprednisolone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Immunocytochemistry of steroid hormone receptors. New aspects of cellular and endocrine physiology
Next Document:  Plasma catecholamines in the acute phase of the response to myocardial infarction.